Prostate-specific antigen-based screening in Afro-Caribbean men: a survey of members of the Caribbean Urological Association

被引:6
|
作者
Persaud, Satyendra [1 ]
Aiken, William D. [2 ]
机构
[1] Univ West Indies, Div Clin Surg Sci, St Augustine, Trinidad Tobago
[2] Univ West Indies, Fac Med Sci, Dept Surg Radiol Anaesthesia & Intens Care, Sect Surg,Div Urol, Mona Campus, Kingston, Jamaica
来源
ECANCERMEDICALSCIENCE | 2018年 / 12卷
关键词
prostate cancer; prostate-specific antigen screening; Afro-Caribbean; Caribbean; urologists;
D O I
10.3332/ecancer.2018.842
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: To examine the attitudes, beliefs and practices of Caribbean urologists regarding prostate-specific antigen (PSA)-based screening in the Caribbean region particularly as it relates to Afro-Caribbean men. Design: An Internet-based descriptive cross-sectional study using a standardised questionnaire designed to capture information on respondents' attitudes, beliefs and practices towards PSA-based screening was conducted using the online survey tool Survey Monkey among known urologists in the Caribbean, based on the complete mailing list of the membership of the Caribbean Urological Association. Results: Thirty of the total population of 40 urologists (75%) from nine countries in the Caribbean completed the survey. Twelve (40%) were from Jamaica and eight (26.7%) were from Trinidad. Two-thirds (n = 20) of the urologists believed that PSA-based screening has positively impacted survival in their population and 76.7% (n = 23) supported the PSA-based screening in the Afro-Caribbean male. Seventy-eight percent believed that guidelines from other countries were not applicable to the Caribbean and 63% believed that a regional body should publish its own guidelines. Most supported yearly screening with the PSA and digital rectal examination beginning at age 40 for Afro-Caribbean men but opinion varied regarding PSA-based screening of Indo-Caribbean men. Respondents were unanimous in their belief that there should be an upper age limit for screening, 75 years old being the most commonly reported. Conclusion: Most Caribbean urologists favour PSA-based screening in Afro-Caribbean men and recommend that Caribbean-specific guidelines need to be drafted.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Prostate-specific antigen-based serial screening may decrease prostate cancer-specific mortality
    Efstathiou, Jason A.
    Chen, Ming-Hui
    Catalona, William J.
    McLeod, David G.
    Carroll, Peter R.
    Moul, Judd W.
    Roehl, Kimberly A.
    D'Amico, Anthony V.
    UROLOGY, 2006, 68 (02) : 342 - 347
  • [32] PREDICTIVE VALUE OF PSA KINETICS ON RISK OF PROSTATE CANCER VERSUS INFLAMMATION IN AN AFRO-CARIBBEAN POPULATION: A SINGLE INSTITUTION BASED RETROSPECTIVE STUDY IN AFRO-CARIBBEAN POPULATION
    Prashil, Dave
    Benjamin, Prizer
    David, Musheyev
    Eli, Berglas
    Nikeeta, Mandhan
    Parima, Saxena
    Luis, Gonzalez Miranda
    Sankalpa, Pokhrel
    Dedipya, Bhamidipati
    Areeba, Zaman
    Andrew, Winer
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2025, 43 (03)
  • [33] Prostate-specific antigen screening in elderly men
    Lu-Yao, G
    Stukel, TA
    Yao, SL
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (23) : 1792 - 1797
  • [34] Beliefs that contribute to delays in diagnosis of prostate cancer among Afro-Caribbean men in Trinidad and Tobago
    King-Okoye, Michelle
    Arber, Anne
    Faithful, Sara
    PSYCHO-ONCOLOGY, 2019, 28 (06) : 1321 - 1327
  • [35] THE EFFECT OF HEALTHCARE BARRIERS ON PSA SCREENING AMONG AFRICAN-AMERICAN AND AFRO-CARIBBEAN MEN
    Lee, Daniel J.
    Consedine, Nathan S.
    Gonzalez, Joshua R.
    Adjei, Brenda
    Spencer, Benjamin A.
    JOURNAL OF UROLOGY, 2009, 181 (04): : 3 - 3
  • [36] Decreasing trend in prostate cancer with high serum prostate-specific antigen levels detected at first prostate-specific antigen-based population screening in Japan
    Kitagawa, Yasuhide
    Machioka, Kazuaki
    Yaegashi, Hiroshi
    Nakashima, Kazufumi
    Ofude, Mitsuo
    Izumi, Kouji
    Ueno, Satoru
    Kadono, Yoshifumi
    Konaka, Hiroyuki
    Mizokami, Atsushi
    Namiki, Mikio
    ASIAN JOURNAL OF ANDROLOGY, 2014, 16 (06) : 833 - 837
  • [37] Outcomes of Prostate-specific Antigen-based Prostate Cancer Screening Among Men Using Nonsteroidal Anti-inflammatory Drugs
    Murtola, Teemu Johannes
    Vettenranta, Arla M.
    Talala, Kirsi
    Taari, Kimmo
    Stenman, Ulf-Hakan
    Tammela, Teuvo L. J.
    Auvinen, Anssi
    EUROPEAN UROLOGY FOCUS, 2018, 4 (06): : 851 - 857
  • [38] Editorial Comment to Predictive value of different prostate-specific antigen-based markers in men with baseline total prostate-specific antigen <2.0 ng/mL
    Kitagawa, Yasuhide
    INTERNATIONAL JOURNAL OF UROLOGY, 2017, 24 (08) : 609 - 610
  • [39] Prostate-specific Antigen-based Risk-adapted Discontinuation of Prostate Cancer Screening in Elderly African American and Caucasian American Men
    Tang, Ping
    Sun, Leon
    Uhlman, Matthew A.
    Robertson, Cary N.
    Polascik, Thomas J.
    Albala, David M.
    Donatucci, Craig F.
    Moul, Judd W.
    UROLOGY, 2010, 76 (05) : 1058 - 1062
  • [40] Prostate-specific antigen-based early detection of prostate cancer -: Validation of screening without rectal examination
    Schröder, FH
    Roobol-Bouts, M
    Vis, AN
    van der Kwast, T
    Kranse, R
    UROLOGY, 2001, 57 (01) : 83 - 90